A M Gray|P R Flatt - JoVE Visualize

Showing results (201-210 of 289) with videos related to

Pageof 29

Sort By:

Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 5, 1998

Power and sample size calculations for stochastic cost-effectiveness analysisA H Briggs, A M Gray

European Journal of Pharmacology|January 5, 1999

Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonismA M Gray, J H Connick

Science (New York, N.Y.)|March 16, 1990

Requirement for activin A and transforming growth factor--beta 1 pro-regions in homodimer assemblyA M Gray, A J Mason

Health Policy (Amsterdam, Netherlands)|May 7, 1996

Labour turnover in the British National Health Service: a local labour market analysisA M Gray, V L Phillips

Regulatory Peptides|June 5, 2004

Isolation and characterisation of an unexpected class of insulinotropic peptides in the skin of the frog Agalychnis litodryasL Marenah, C Shaw, D F Orr, et al.

Diabetologia|July 21, 2012

Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetesN Irwin, P Frizelle, I A Montgomery, et al.

Archives of Biochemistry and Biophysics|July 13, 2004

Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acidB D Green, V A Gault, P R Flatt, et al.

Diabetologia|March 1, 1985

Influence of a transplantable insulinoma on the pancreatic status of insulin and pancreatic polypeptide in the ratM M O'Hare, C Shaw, S K Swanston-Flatt, et al.

Clinical Medicine Insights. Endocrinology and Diabetes|September 25, 2019

Characterisation of Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonists in Rodent Pancreatic Beta Cells and MiceR A Perry, S L Craig, M T Ng, et al.

Diabetologia|May 9, 2007

Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob miceN Irwin, P L McClean, F P M O'Harte, et al.

Pageof 29

Showing results (201-210 of 289) with videos related to

Sort By:

Pageof 29

Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 5, 1998

Power and sample size calculations for stochastic cost-effectiveness analysisA H Briggs, A M Gray

European Journal of Pharmacology|January 5, 1999

Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonismA M Gray, J H Connick

Science (New York, N.Y.)|March 16, 1990

Requirement for activin A and transforming growth factor--beta 1 pro-regions in homodimer assemblyA M Gray, A J Mason

Health Policy (Amsterdam, Netherlands)|May 7, 1996

Labour turnover in the British National Health Service: a local labour market analysisA M Gray, V L Phillips

Regulatory Peptides|June 5, 2004

Isolation and characterisation of an unexpected class of insulinotropic peptides in the skin of the frog Agalychnis litodryasL Marenah, C Shaw, D F Orr, et al.

Diabetologia|July 21, 2012

Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetesN Irwin, P Frizelle, I A Montgomery, et al.

Archives of Biochemistry and Biophysics|July 13, 2004

Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acidB D Green, V A Gault, P R Flatt, et al.

Diabetologia|March 1, 1985

Influence of a transplantable insulinoma on the pancreatic status of insulin and pancreatic polypeptide in the ratM M O'Hare, C Shaw, S K Swanston-Flatt, et al.

Clinical Medicine Insights. Endocrinology and Diabetes|September 25, 2019

Characterisation of Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonists in Rodent Pancreatic Beta Cells and MiceR A Perry, S L Craig, M T Ng, et al.

Diabetologia|May 9, 2007

Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob miceN Irwin, P L McClean, F P M O'Harte, et al.

Pageof 29